Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT02445469
Eligibility Criteria:
Inclusion Criteria:
* For Both patients and healthy volunteers :
* Age limits ≥ 70 et ≤ 90 years
* Subject able to understand the nature, the aim and the methodology of the study.
* Collection of the infomed consent
* Affiliation or recipient with the mode of social security.
* For the patients :
Parkinsonian Syndrome began after 65 years defined as Parkinson's disease Multiple System Atrophy (AMS), Progressive Supranuclear Palsy, Vascular Parkinson
* For the healthy volunteers :
The healthy volunteers will be selected according to the age and the of the study's patients.
Exclusion Criteria:
* For Both patients and healthy volunteers :
* Person with majority age protected by the law (supervision or trusteeship).
* Loss of liberty per court order or administative
* Subject presenting contraindications in MRI (valve of ventricular diversion, Ferromagnetic foreign bodies, pace-maker, Implantable defibrillator (ICD), Cochlear hearing implant, Claustrophobia, ….)
* Antecedent of serious cranial trauma (according to classification) of ischeamic stroke ou intracranial hematoma.
* For the patients :
•Patient treated by neuroleptics
* For the healthy volunteers :
* Antecedent of neurological desease
* Antecedent of psychiatric trouble de trouble psychiatrique (Except anxio-depressive disorder)
* In period of exclusion relative to another protocol or which the annual amount of the allowances maximum of 4500 € was reached.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
70 Years
Maximum Age:
90 Years
Study:
NCT02445469
Study Brief:
Protocol Section:
NCT02445469